Article
Variants other than aspartic acid at codon 69 of the human immunodeficiency virus type 1 reverse transcriptase gene affect susceptibility to nuleoside analogs.
Antimicrobial agents and chemotherapy - 1 Aug 2001
Winters M A, Merigan T C
Abstract excerpt
The T69D mutation in the human immunodeficiency virus type 1 reverse transcriptase (RT) gene has been associated with reduced susceptibility to dideoxycytosine (ddC); however, several other mutations at codon 69 have been observed in antiretroviral drug-treated patients. The Stanford HIV RT and Protease Sequence Database was interrogated and showed that 23% of patients treated with nucleoside RT inhibitors (NRTI)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
